Straits Times Index
3,322.62 +14.72 (+0.45%) S&P 500
5,307.01 -14.40 (-0.27%) Dow
39,671.04 -201.95 (-0.51%) Nasdaq
16,801.54 -31.08 (-0.18%) Bitcoin USD
69,738.18 -414.74 (-0.59%) CMC Crypto 200
1,502.60 -0.06 (-0.00%)
Satellos Bioscience Inc. (0ITA.F)
| Previous close | 0.2840 |
| Open | 0.2840 |
| Bid | 0.2980 x N/A |
| Ask | 0.3500 x N/A |
| Day's range | 0.2840 - 0.2840 |
| 52-week range | 0.1680 - 0.5200 |
| Volume | |
| Avg. volume | 5 |
| Market cap | 35.801M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
TORONTO, May 14, 2024--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today the results of its Annual and Special Meeting of Shareholders held today, May 14, 2024 (the "Meeting").
- Business Wire
Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
TORONTO, May 14, 2024--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today its financial results and operational highlights for the three months ended March 31, 2024. All references to currency in this press release are in Canadian dollars unless otherwise noted.
- Business Wire
Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 08, 2024--Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today that management will present at and participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16th and 17th in Toronto.
